The relationship between anthropometric indexes of adiposity and vascular function in the FATE cohort

Obesity

Volumn 21, Issue 2, 2013, Pages 266-273

  Martin, Billie Jean ^a   Verma, Subodh ^b   Charbonneau, Francois ^a   Title, Lawrence M ^c   Lonn, Eva M ^d   Anderson, Todd J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; BODY MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; FIRE FIGHTER; FLOW MEDIATED DILATION; HUMAN; HYPEREMIC SHEAR STRESS; HYPEREMIC VELOCITY TIME INTEGRAL; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; VASODILATATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOSITY; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FIREFIGHTERS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84876281220     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.113     Document Type: Article

References (41)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010:235-241.
2. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-952. (Pubitemid 39208455)
3. McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005;15:87-97. (Pubitemid 40126638)
4. Canoy D, Boekholdt SM, Wareham N et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007;116:2933-2943. (Pubitemid 350291200)
5. Balkau B, Deanfield JE, Després JP et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116:1942-1951. (Pubitemid 350287090)
6. Goodpaster BH, Krishnaswami S, Resnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003;26:372-379. (Pubitemid 36929058)
7. Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001;88:1264-1269. (Pubitemid 33132095)
8. Parikh NI, Keyes MJ, Larson MG et al. Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009;17:2054-2059.
9. Hamburg NM, Keyes MJ, Larson MG et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117:2467-2474. (Pubitemid 351670453)
10. Mitchell GF, Parise H, Vita JA et al. Local shear stress and brachial artery flowmediated dilation: the Framingham Heart Study. Hypertension 2004;44:134-139. (Pubitemid 39014228)
11. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366: 1640-1649. (Pubitemid 41552419)
12. Cepeda-Valery B, Pressman GS, Figueredo VM, Romero-Corral A. Impact of obesity on total and cardiovascular mortality-fat or fiction? Nat Rev Cardiol 2011;8: 233-237.
13. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0-5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269.
14. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003;179:580-585. (Pubitemid 37536577)
15. Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007;61:1373-1379. (Pubitemid 350245910)
16. Anderson TJ, Charbonneau F, Title LM et al. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 2011;123:163-169.
17. Anderson TJ, Roberts AC, Hildebrand K et al. The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol 2003;19:61-66. (Pubitemid 36304701)
18. Bergman RN, Stefanovski D, Buchanan TA et al. A better index of body adiposity. Obesity (Silver Spring) 2011;19:1083-1089.
19. Yan RT, Yan AT, Anderson TJ et al. The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. Atherosclerosis 2009;207:232-238.
20. Yan RT, Anderson TJ, Charbonneau F et al. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005;45:1980-1986. (Pubitemid 40814118)
21. Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265. (Pubitemid 34084631)
22. Meredith IT, Currie KE, Anderson TJ et al. Post-ischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996;270: H1435-H1440.
23. Philpott A, Anderson TJ. Reactive hyperemia and cardiovascular risk. Arterioscler Thromb Vasc Biol 2007;27:2065-2067. (Pubitemid 350287232)
24. Philpott AC, Lonn E, Title LM et al. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol 2009;103:1610-1615.
25. Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
26. Organization WHO. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008.
27. Després JP, Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039-1049.
28. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005;288: H2031-H2041. (Pubitemid 40604084)
29. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
30. Shimabukuro M, Higa N, Asahi T et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003;88:3236-3240. (Pubitemid 36877499)
31. Shankar SS, Steinberg HO. Obesity and endothelial dysfunction. Semin Vasc Med 2005;5:56-64. (Pubitemid 40721046)
32. Steinberg HO, Paradisi G, Hook G et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000;49: 1231-1238. (Pubitemid 30439100)
33. Lundman P, Tornvall P, Nilsson L, Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 2001;159:35-41. (Pubitemid 33016619)
34. Couloubaly S, Deloménie C, Rousseau D et al. Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur J Clin Invest 2007;37: 692-699. (Pubitemid 47256169)
35. de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004;109:2529-2535. (Pubitemid 38720552)
36. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001;37:1523-1528.
37. Worthley MI, Curtis MJ, Goodhart DM, Anderson TJ. Obesity is associated with impaired human coronary endothelial function. Obes Res Clin Pract 2009;3:9-15.
38. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007;115:2390-2397. (Pubitemid 46717961)
39. Hu FB. Obesity Epidemiology, 1st edn. Oxford University Press: Oxford, 2008.
40. Burke GL, Bertoni AG, Shea S et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008;168:928-935. (Pubitemid 351679632)
41. Title LM, Lonn E, Charbonneau F et al. Relationship between brachial artery flowmediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med 2008;13:263-270.